Emerald Investment Advisers, LLC
Source: SEC Form 13F · as of Mar 2026Emerald Investment Advisers, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $87.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$87.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 12,918 | $11.9M |
| LGNDLigand Pharmaceuticals Incorporated | 44,226 | $8.8M |
| ABBVAbbVie Inc. | 37,701 | $8.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 25,651 | $6.9M |
| JNJJOHNSON & JOHNSON | 25,409 | $6.2M |
| PFEPFIZER INC | 214,657 | $6.0M |
| ANIPANI PHARMACEUTICALS INC | 66,012 | $5.1M |
| AXSMAxsome Therapeutics, Inc. | 27,386 | $4.6M |
| REGNREGENERON PHARMACEUTICALS, INC. | 5,388 | $4.2M |
| AMGNAMGEN INC | 11,521 | $4.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 8,012 | $3.6M |
| MRKMerck & Co., Inc. | 26,804 | $3.2M |
| ICUIICU Medical Inc. | 23,874 | $3.1M |
| MMSIMerit Medical Systems Inc. | 42,464 | $2.9M |
| PBHPrestige Consumer Healthcare Inc. | 47,314 | $2.8M |
| TARSTarsus Pharmaceuticals, Inc. | 39,896 | $2.8M |
| ACADACADIA PHARMACEUTICALS INC | 110,039 | $2.4M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 13,819 | $763K |
| PGNYProgyny Inc. | 14,905 | $253K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.